Related Experiment Video

Updated: Dec 8, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

4.3K

Recent Advances in Understanding, Diagnosing, and Treating Hepatitis B Virus Infection

Magda Rybicka1, Krzysztof Piotr Bielawski1

  • 1Department of Molecular Diagnostics, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Abrahama 58, 80-307 Gdansk, Poland.

Microorganisms
|September 18, 2020
PubMed

Insights

Chronic hepatitis B (HBV) infection impacts millions globally, causing severe liver disease. While current treatments manage HBV, new research explores novel antivirals and diagnostics for a potential cure.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Chronic hepatitis B virus (HBV) infection affects 292 million people worldwide.
  • HBV infection is linked to severe liver conditions like cirrhosis, liver failure, and hepatocellular carcinoma (HCC).
  • Despite vaccination, HBV causes approximately 900,000 deaths annually, with current treatments unable to eliminate the virus completely.

Purpose of the Study:

  • To review recent advances in understanding HBV biology and replication.
  • To highlight novel diagnostic markers for hepatitis B infection.
  • To summarize emerging antiviral therapies targeting various stages of the HBV lifecycle.

Main Methods:

  • Review of recent scientific literature on HBV.
  • Analysis of host and viral mechanisms in HBV replication.
  • Examination of new diagnostic and therapeutic strategies.

Main Results:

  • Development of reliable cell culture systems has improved understanding of HBV replication.
  • New diagnostic markers show potential for improved hepatitis B detection.
  • Novel antivirals targeting different steps in the HBV replication cycle are emerging.

Conclusions:

  • Advances in HBV biology and cell culture models offer new insights.
  • Novel diagnostics and antivirals represent promising future directions for HBV management.
  • Complete viral clearance remains a goal for future hepatitis B therapies.

Keywords:
HBVHBV RNAHBcrAgdirect-acting antiviralsnovel viral markers

More Related Videos

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.8K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.5K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
101
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.7K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
515
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.8K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
748